NOVITAPHARM

Serial Number 90813439
602

Registration Progress

Application Filed
Jul 6, 2021
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
90813439
Filing Date
July 6, 2021
Abandonment Date
March 13, 2023
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Apr 24, 2023
Classes
005

Rights Holder

Novita Pharmaceuticals, Inc.

03
Address
1161 York Avenue 8C
New York, NY 10065

Ownership History

Novita Pharmaceuticals, Inc.

Original Applicant
03
New York, NY

Legal Representation

Attorney
Tricia L. Schulz

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description
Apr 24, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 24, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 24, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 12, 2022 CNFR R FINAL REFUSAL WRITTEN
Sep 12, 2022 GNFR O FINAL REFUSAL E-MAILED
Sep 12, 2022 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 2, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2022 CNRT R NON-FINAL ACTION WRITTEN
Feb 2, 2022 GNRT F NON-FINAL ACTION E-MAILED
Feb 2, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 31, 2022 DOCK D ASSIGNED TO EXAMINER
Sep 16, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 15, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a square design with rounded corners with an arc of various sized dots going from the top left corner down to the bottom right corner inside, followed by the word "NOVITAPHARM".

Classification

International Classes
005